All In Biotech

Drug Trial Radar · NCT07670312

Evaluation of XYA02 in Patients With Advanced Solid Tumors

A Phase 1b/2, Multicenter, Non-randomized, Open-label, Multiple Dose First- In-Human Study of XYA02 in Patients With Advanced Solid Tumors

Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

190

Planned (sponsor's estimate)

Start

Sep 17, 2026

Primary completion

Sep 15, 2029

Study completion Sep 15, 2030

Sponsor

Lead sponsor
XYone Therapeutics, IncIndustry
Sponsor type
Industry
Collaborators
Novotech (Australia) Pty Limited
First posted
Jun 26, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the safety, tolerability, and efficacy of XYA02 in participants with advanced solid tumors.

Conditions

  • MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors
  • Non-Small Cell Lung Cancer
  • Ovarian Cancer
  • GEJ Adenocarcinoma
  • Colorectal Cancer
  • Pancreatic Adenocarcinoma
  • Gastric Cancer

Interventions

  • XYA02Biological

    IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Frequency of Treatment Emergent Adverse Events of XYA02Time frame: From enrollment for a minimum of 16 weeks
  2. Duration of Treatment Emergent Adverse Events of XYA02Time frame: From enrollment for a minimum of 16 weeks
  3. Severity of Treatment Emergent Adverse Events of XYA02Time frame: From enrollment for a minimum of 16 weeks
  4. Determine the Maximum Tolerated Dose (MTD) of XYA02Time frame: From enrollment to a minimum of 16 weeks per participant

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Chris O'Brien Life House

    Sydney, New South Wales, Australia · Not yet recruiting

  • Westmead Hospital

    Sydney, New South Wales, Australia · Not yet recruiting

  • Monash Medical Centre

    Melbourne, Victoria, Australia · Not yet recruiting

  • Peter MacCallum Cancer Centre

    Melbourne, Victoria, Australia · Recruiting

  • Linear Clinical Research

    Perth, Western Australia, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.